Wheel adds Mark Cuban Cost Plus, Talkspace and Health Gorilla to virtual care platform

Wheel adds Mark Cuban Cost Plus, Talkspace and Health Gorilla to virtual care platform
Preview
Source: mobihealthnews
Photo: RichLegg/Getty Images
Wheel, a virtual care staffing and services vendor, announced it has partnered with Mark Cuban Cost Plus Drug Company, mental health platform Talkspace and diagnostic services company Health Gorilla.
Thanks to the collaborations, Wheel will deliver mental health services, affordable home delivery prescription drug pricing offerings, and lab and diagnostics through its integrated virtual care ecosystem.
All three companies will be available to Wheel customers on the platform this year.
"The addition of Talkspace, Mark Cuban Cost Plus Drug Company and Health Gorilla to the Wheel ecosystem is not just about expanding our capabilities; it's about fortifying our commitment to providing patients with unparalleled choice, accessibility, and affordability in their healthcare journey," Wheel CEO and cofounder Michelle Davey told MobiHealthNews via email.
"These partnerships represent a step toward breaking down barriers to care, ensuring that patients can access high-quality services seamlessly, conveniently and at a lower cost. And for virtual care providers, our platform's integrated ecosystem partners equip them with a robust tool kit to deliver comprehensive, patient-centric care at scale."
THE LARGER TREND
Last year, Wheel laid off 28% of its workforce or 56 employees less than a year after letting go of 17% of its staff.
In 2022, the company scored $150 million in a Series C funding round. In 2021 it had gained $50 million in a Series B round.
Other telehealth platforms include self-pay marketplace Sesame Care, California-based Healthtap, Teledoc Health, and tech-enabled women’s health-focused company Maven Clinic.
Tags: Wheel, Health Gorilla, Talkspace, Mark Cuban Cost Plus Drug Company, integrated telehealth
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.